Skip to Main Content

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of Zoom meetings, Skype calls, and deadlines has predictably returned. But what can you do? The world keeps spinning, after all. So time to give it a bit of a nudge with a delicious cup of stimulation. Our choice today is cinnamon mocha. Yum. Feel free to join us. Meanwhile, here are some tidbits to help you along. We hope your day is productive and free of stress. Meanwhile, stay safe — wear that mask. …

BioNTech (BNTX), which joined with Pfizer (PFE) to make the first Covid-19 vaccine in the West, is building a new manufacturing alliance that could throw Europe and the rest of the world a lifeline amid a painful shortage of shots and a rebound in infections, The Wall Street Journal writes. The company has marshaled an alliance of 13 companies, including Novartis (NVS),  Merck (MRK), and Sanofi (SNY), in an effort to meet — and perhaps exceed — an ambitious target of making 2 billion doses of vaccine this year.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!